Pain Management Devices Market (By Product Type: Electrical Stimulation Devices, Radiofrequency (RF) Ablation Devices, Neuromodulation Devices, Infusion Pumps; By Application: Musculoskeletal, Brain, Cancer, Neuropathy, and Others; By End User: Physiotherapy Centers, Hospitals and Clinics, and Others) - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Pain Management Devices market size was estimated at USD 4.11 billion in 2021 and is expected to surpass around USD 8.58 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 8.5% during the forecast period 2022 to 2030.

Pain is an unpleasant sensory and emotional experience caused due to tissue damage or illness. It is caused due to injury and various diseases such as osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer, fibromyalgia and cancer. It can be classified on the basis of duration as acute pain and chronic pain.

Acute pain is sudden onset of pain where as chronic pain persists for long periods. Chronic pain is mainly caused due to aging conditions of bone and joints and nerve damage and injury. Pain is managed by a particular set of drugs or devices to treat pain.

Transcutaneous electrical nerve stimulators, neuro-stimulators, analgesia infusion pumps and radiofrequency ablators are some of the pain management devices. Most of these devices block the pain gate mechanism, to block the passage of pain signals to the brain.

Radiofrequency ablators destroys nerves by generating heat to block the pain signals, Similarly, neuro-stimulator devices uses mild frequencies of current to block the passage of pain signals. These devices help in treating various painful conditions such as cancer, musculoskeletal injury and neuropathic pain. Pain management devices help to reduce the risk of long term narcotics, non-steroidal anti-inflammatory drugs, and other pain relieving medications.

Report Scope of the Pain Management Devices Market

Report Coverage


Market Size

US$ 8.58 Billion by 2030

Growth Rate

CAGR of 8.5% from 2022 to 2030

Largest Market

North America

Fastest Growing Market

Asia Pacific

Base Year


Forecast Period

2022 to 2030

Segments Covered

By Type, By Application, By Mode of Purchase and Region,

Companies Mentioned

 Medtronic PLC (Ireland), Boston Scientific (US), Abbott (US), Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), Stryker (US), Smiths Medical (US), Moog Inc. (US), Avanos Medical, Inc. (US), Nipro Corporation (Japan), Atricure (US), Nevro Corp. (US), Micrel Medical Devices SA (Greece), InfuTronix Solutions LLC (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Shenzhen MedRena Biotech Co., Ltd. (China), Epic Medical (Singapore), Bioness (US), Microtransponder (US), Neuronano (Sweden), Gimer Medical (Taiwan), Bluewind Medical (Israel), Soterix Medical Inc. (US) and other players (Total 25 companies)

 Drivers: Growing number of surgical procedures performed

Over the years, there has been a significant rise in the number of surgical procedures performed across the globe. This can be attributed to the rising geriatric population and the growing prevalence of obesity and other lifestyle diseases. Obesity is one of the key causes of cardiovascular and orthopedic diseases. Analgesia/pain management is the key application area of infusion pumps. Infusion pumps are also widely used for the local administration of narcotic analgesics and anesthetics following bariatric surgery, cardiothoracic surgery, and laparoscopic cholecystectomy.

PCA pumps are used to manage post-operative pain in various orthopedic surgeries such as spine surgeries and in major joint and foot/lower extremity surgical procedures. According to the National Spinal Cord Injury Statistical Center (NSCISC) 2016 datasheet, the annual incidence of spinal cord injuries (SCI) is approximately 54 cases per million population in the US or approximately 17,000 new SCI cases each year. According to the NCBI, more than 51 million inpatient surgical procedures are performed annually in the US alone, and approximately 90% of all hospitalized patients receive medications through IV. With an increase in the number of surgeries performed, the demand for infusion therapy is expected to increase.
Restraints: Product recalls

Pain management devices are used to administer critical fluids, neurostimulations and ablation that involves including high-risk medications. Errors in using these systems can cause serious harm to patients and may even lead to death. According to the Institute of Medicine (US), approximately 1.5 million patients annually experience medication errors costing USD 8,750 per Potential Adverse Drug Event (PADE).

In the past five years, the Emergency Care Research Institute (ECRI) has been pointing out errors in drug administration involving the use of infusion pumps in its Top 10 list of health technology hazards. The recall of these products due to safety and efficacy failures is a key concern for device manufacturers as it affects the sales of pain management devices. These recall activities require manufacturers to replace erroneous device with updated models and compel them to pay for serious injuries in mishaps. Hence, product recalls affect the growth of the overall pain management devices market.

Opportunities: High growth in emerging markets

Emerging economies such as China, India, and Brazil offer significant growth opportunities for players in the pain management devices market. This can primarily be attributed to the diversified healthcare markets in this region, the growing incidence of chronic disorders, and increasing R&D initiatives to develop innovative medical technologies. In addition, infrastructural developments in healthcare facilities, increasing healthcare expenditures, and the low-cost manufacturing advantage offered by emerging countries in the Asia Pacific are expected to encourage market players to invest in this region in the coming years.

Challenges: Use of pain medications as the first line of treatment for pain management

Medication is often the first therapy that doctors use to manage chronic pain. Pain specialists prefer to prescribe medications over devices to patients suffering from pain majorly due to their easy availably, presence of substantial clinical evidence, and lower cost. Usually, physicians opt for pain management devices such as TENS or SCS only if medication and other alternative treatments do not work.

North America holds the largest share in this market

North America dominated the pain management devices market, with a share of 53.% in 2021, followed by Europe and Asia Pacific. North America is expected to grow at a 7.9% CAGR during the forecast period. North America has been among the frontrunners in developing pain management devices services in the healthcare industry. The pain management devices market in the US is expected to offer growth opportunities in the coming years owing to the increasing incorporation of pain management devices in the ambulatory care centers. Many major global players are also based in the US, owing to which the country has become a center of innovation in the pain management devices market.

Some of the prominent players in the Pain Management Devices Market include:

  • Nevro Corporation
  • LivaNova
  • SPR Therapeutics
  • Boston Scientific Corporation
  • Abbott
  • DJO Global LLC
  • Medtronic
  • Omron Healthcare Inc.
  • Smiths Medical
  • Melsungen AG

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Pain Management Devices market

By Product Type

  • Electrical Stimulation Devices
    • TENS
    • Others
  • Radiofrequency (RF) Ablation Devices
  • Neuromodulation Devices
    • Spinal Cord Stimulators
    • Deep Brain Stimulators
    • Sacral Neurostimulators
    • Others
  • Infusion Pumps
    • Intrathecal Infusion Pumps
    • External Infusion Pumps

By Application

  • Musculoskeletal
  • Brain
  • Cancer
  • Neuropathy
  • Others

By End User

  • Physiotherapy Centers
  • Hospitals and Clinics
  • Others

By Geography

North America

  • U.S.
  • Canada


  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Pain Management Devices industry analysis from 2022 to 2030 to identify the prevailing Pain Management Devices industry opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the global Pain Management Devices industry segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global Pain Management Devices industry trends, key players, market segments, application areas, and market growth strategies.